A novel gene mutation in PANK2 in a patient with severe jaw-opening dystonia

[1]  M. Rodríguez-Violante,et al.  Clinical, imaging, and molecular findings in a sample of Mexican families with pantothenate kinase‐associated neurodegeneration , 2015, Clinical genetics.

[2]  K. Bhatia,et al.  The genetics of dystonia: new twists in an old tale , 2013, Brain : a journal of neurology.

[3]  S. Schneider,et al.  Dystonic opisthotonus: A “red flag” for neurodegeneration with brain iron accumulation syndromes? , 2013, Movement disorders : official journal of the Movement Disorder Society.

[4]  J. Hardy,et al.  Syndromes of neurodegeneration with brain iron accumulation (NBIA): An update on clinical presentations, histological and genetic underpinnings, and treatment considerations , 2012, Movement disorders : official journal of the Movement Disorder Society.

[5]  J. Trojanowski,et al.  Altered Neuronal Mitochondrial Coenzyme A Synthesis in Neurodegeneration with Brain Iron Accumulation Caused by Abnormal Processing, Stability, and Catalytic Activity of Mutant Pantothenate Kinase 2 , 2005, The Journal of Neuroscience.

[6]  J. Jankovic,et al.  Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden‐Spatz syndrome) and pantothenate kinase‐associated neurodegeneration , 2004, Movement disorders : official journal of the Movement Disorder Society.

[7]  E. Dietrichs,et al.  Jaw‐opening dystonia presumably caused by a pontine lesion , 2000, Movement disorders : official journal of the Movement Disorder Society.

[8]  J. Perlmutter,et al.  Chorea and jaw‐opening dystonia as a manifestation of Neurobehcet's syndrome , 2000, Movement disorders : official journal of the Movement Disorder Society.

[9]  Y. Kitagawa,et al.  GM1 gangliosidosis type 3 with severe jaw-closing impairment , 1997, Journal of the Neurological Sciences.

[10]  M. Brin,et al.  Botulinum Toxin Injection for the Treatment of Oromandibular Dystonia , 1989, The Annals of otology, rhinology, and laryngology.